Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

Yamanouchi files for approval of hypoglycemic agent

Oct. 15, 1997

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Oct. 15, 1997

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

Oct. 14, 1997

Heterocyclic compounds from Zeneca for hypercholesterolemia

Oct. 14, 1997

Gonal-F approved for marketing in U.S.

Oct. 13, 1997

Cambridge NeuroScience awarded sixteenth SBIR grant

Oct. 13, 1997

Roussel Uclaf develops estrogenic compounds

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...